Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody prevalence in a healthcare worker population exceeded self-reported infection rates, 2020
A study of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroprevalence at a healthcare institution prior to the availability of vaccine showed that seroprevalence in the cohort increased over 6 months from 25% to 55%. The number of employees with antibodies was higher than the number wh...
Saved in:
Main Authors: | Susan E. Hoover (Author), Valerie Reed (Author) |
---|---|
Format: | Book |
Published: |
Cambridge University Press,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antibodies in healthcare personnel following severe acute respiratory syndrome coronavirus virus 2 (SARS-CoV-2) infection
by: Rachel E. Bosserman, et al.
Published: (2022) -
Seroprevalence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) antibodies among healthcare personnel in the Midwestern United States, September 2020-April 2021
by: Rachel E. Bosserman, et al.
Published: (2023) -
Coronavirus (SARS-CoV-2) and Mortality Rate in India: The Winning Edge
by: Gyaneshwer Chaubey
Published: (2020) -
Detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) specific antibodies and T-cell immunity response in pregnant women and neonates
by: Chih Lin, et al.
Published: (2023) -
Risk assessment and antibody responses to SARS-CoV-2 in healthcare workers
by: Amit Bansal, et al.
Published: (2023)